Paper41228271
The Role of Porphyromonas gingivalis in Oral Carcinogenesis and Progression by Remodelling the Tumour Microenvironment: A Narrative Review.
Starska-Kowarska K. Cancers (Basel), 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The Role of Porphyromonas gingivalis in Oral Carcinogenesis and Progression by Remodelling the Tumour Microenvironment: A Narrative Review. Papers, record 41228271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41228271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Role of Porphyromonas gingivalis in Oral Carcinogenesis and Progression by Remodelling the Tumour Microenvironment: A Narrative Review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References154
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26639759 | Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells. | Cell Microbiol | 2016 | https://conductscience.org/library/papers/26639759 | PubMed |
| 2 | 33708214 | New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries. | Front Immunol | 2021 | https://conductscience.org/library/papers/33708214 | PubMed |
| 3 | 33777334 | The oralome and its dysbiosis: New insights into oral microbiome-host interactions. | Comput Struct Biotechnol J | 2021 | https://conductscience.org/library/papers/33777334 | PubMed |
| 4 | 21536793 | Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. | Infect Immun | 2011 | https://conductscience.org/library/papers/21536793 | PubMed |
| 5 | 31243990 | Porphyromonas gingivalis Infection Promoted the Proliferation of Oral Squamous Cell Carcinoma Cells through the miR-21/PDCD4/AP-1 Negative Signaling Pathway. | ACS Infect Dis | 2019 | https://conductscience.org/library/papers/31243990 | PubMed |
| 6 | 25047843 | Porphyromonas gingivalis-induced reactive oxygen species activate JAK2 and regulate production of inflammatory cytokines through c-Jun. | Infect Immun | 2014 | https://conductscience.org/library/papers/25047843 | PubMed |
| 7 | 33731837 | Regulation of olfactomedin 4 by Porphyromonas gingivalis in a community context. | ISME J | 2021 | https://conductscience.org/library/papers/33731837 | PubMed |
| 8 | 33668576 | Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression. | Cells | 2021 | https://conductscience.org/library/papers/33668576 | PubMed |
| 9 | 29868494 | Maturation of the Mfa1 Fimbriae in the Oral Pathogen Porphyromonas gingivalis. | Front Cell Infect Microbiol | 2018 | https://conductscience.org/library/papers/29868494 | PubMed |
| 10 | 26158901 | Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. | Oncotarget | 2015 | https://conductscience.org/library/papers/26158901 | PubMed |
| 11 | 22875665 | Porphyromonas gingivalis LPS stimulation downregulates DNMT1, DNMT3a, and JMJD3 gene expression levels in human HaCaT keratinocytes. | Clin Oral Investig | 2013 | https://conductscience.org/library/papers/22875665 | PubMed |
| 12 | 38276166 | The Roles and Interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in Oral and Gastrointestinal Carcinogenesis: A Narrative Review. | Pathogens | 2024 | https://conductscience.org/library/papers/38276166 | PubMed |
| 13 | 23201354 | The oral microbiome in health and disease. | Pharmacol Res | 2013 | https://conductscience.org/library/papers/23201354 | PubMed |
| 14 | 37954619 | The emerging role of oral microbiota in oral cancer initiation, progression and stemness. | Front Immunol | 2023 | https://conductscience.org/library/papers/37954619 | PubMed |
| 15 | 32038557 | Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. | Front Microbiol | 2019 | https://conductscience.org/library/papers/32038557 | PubMed |
| 16 | 34774023 | Fusobacterium nucleatum and oral cancer: a critical review. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34774023 | PubMed |
| 17 | 24618402 | GSK3β and the control of infectious bacterial diseases. | Trends Microbiol | 2014 | https://conductscience.org/library/papers/24618402 | PubMed |
| 18 | 31308358 | Clinical update on head and neck cancer: molecular biology and ongoing challenges. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31308358 | PubMed |
| 19 | 36897441 | Macrophages immunomodulation induced by Porphyromonas gingivalis and oral antimicrobial peptides. | Odontology | 2023 | https://conductscience.org/library/papers/36897441 | PubMed |
| 20 | 25631445 | Comprehensive genomic characterization of head and neck squamous cell carcinomas. | Nature | 2015 | https://conductscience.org/library/papers/25631445 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42898724 | Intratumoral microbiota and their emerging role in the tumor microenvironment. | Microbiome Res Rep | 2026 | https://conductscience.org/library/papers/42898724 | PubMed |
| 42871354 | Cross-organ microbes modulate host upper gastrointestinal health and disease via the oral-gastric microbiome axis. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42871354 | PubMed |
| 42482202 | The oral microbiota in oral squamous cell carcinoma: unravelling mechanisms and clinical potential. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42482202 | PubMed |
| 42070249 | The Silent Link: Exploring the Impact of Periodontal Diseases on Head and Neck Carcinogenesis. | Clin Exp Dent Res | 2026 | https://conductscience.org/library/papers/42070249 | PubMed |
| 41838299 | Early modulatory effects of Porphyromonas gingivalis and Lactobacillus salivarius on oncogenic processes in dysplastic oral keratinocytes. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41838299 | PubMed |
| 41828887 | Porphyromonas gingivalis-Associated Modulation of β-Catenin Signaling in Oral Squamous Cell Carcinoma: Molecular Perspectives from Periodontal Dysbiosis. | Molecules | 2026 | https://conductscience.org/library/papers/41828887 | PubMed |
| 41737112 | A Narrative Review on Oral Microbiome Dysbiosis in Benign and Malignant Oral Lesions: Mechanistic Insights and Clinical Implications. | Cureus | 2026 | https://conductscience.org/library/papers/41737112 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41228271
GET https://conductscience.org/api/papers/v1/41228271/references?page=2